Thomas P. Haverty

2.0k total citations
28 papers, 1.7k citations indexed

About

Thomas P. Haverty is a scholar working on Surgery, Nephrology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas P. Haverty has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Nephrology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas P. Haverty's work include Renal Transplantation Outcomes and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Thomas P. Haverty is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Thomas P. Haverty collaborates with scholars based in United States, Poland and Australia. Thomas P. Haverty's co-authors include Eric G. Neilson, Gerald S. Kuncio, M. Watanabe, C J Kelly, René Alvarez, William H. Hines, Peter S. Amenta, Robert A. Harper, Fuad N. Ziyadeh and Nicholas A. Kefalides and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Thomas P. Haverty

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas P. Haverty United States	18	489	442	426	387	246	28	1.7k
F Mampaso Spain	24	656 1.3×	390 0.9×	647 1.5×	265 0.7×	413 1.7×	90	2.0k
Hidekazu Shigematsu Japan	22	798 1.6×	446 1.0×	329 0.8×	374 1.0×	257 1.0×	129	1.9k
Yukinari Masuda Japan	21	661 1.4×	579 1.3×	232 0.5×	232 0.6×	131 0.5×	52	1.7k
Andrew W. Minto United States	23	775 1.6×	571 1.3×	591 1.4×	170 0.4×	117 0.5×	36	2.0k
Yasunori Utsunomiya Japan	26	776 1.6×	785 1.8×	326 0.8×	428 1.1×	110 0.4×	92	2.0k
Hideo Shiiki Japan	24	751 1.5×	488 1.1×	512 1.2×	170 0.4×	371 1.5×	70	2.0k
H. Terence Cook United Kingdom	22	994 2.0×	370 0.8×	824 1.9×	245 0.6×	704 2.9×	45	2.3k
J J Weening Netherlands	17	296 0.6×	196 0.4×	351 0.8×	121 0.3×	113 0.5×	34	1.1k
Huiping Chen China	20	466 1.0×	273 0.6×	153 0.4×	164 0.4×	207 0.8×	56	1.2k
Nancy A. Noble United States	7	768 1.6×	910 2.1×	127 0.3×	287 0.7×	104 0.4×	8	2.0k

Countries citing papers authored by Thomas P. Haverty

Since Specialization

Citations

This map shows the geographic impact of Thomas P. Haverty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Haverty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Haverty more than expected).

Fields of papers citing papers by Thomas P. Haverty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Haverty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Haverty. The network helps show where Thomas P. Haverty may publish in the future.

Co-authorship network of co-authors of Thomas P. Haverty

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Haverty. A scholar is included among the top collaborators of Thomas P. Haverty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Haverty. Thomas P. Haverty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haverty, Thomas P., et al.. (2020). Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX‐02 in Patients With Nephropathic Cystinosis. The Journal of Clinical Pharmacology. 61(7). 923–931. 6 indexed citations

Kim, Yae‐Jean, Calman Prussin, Brian M. Martin, et al.. (2004). Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700. Journal of Allergy and Clinical Immunology. 114(6). 1449–1455. 87 indexed citations

Klion, Amy D., Melissa Law, Pierre Noël, et al.. (2003). Safety and efficacy of the monoclonal anti–interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood. 103(8). 2939–2941. 129 indexed citations

Woodle, E. Steve, Danlin Xu, Robert A. Zivin, et al.. (1999). PHASE I TRIAL OF A HUMANIZED, Fc RECEPTOR NONBINDING OKT3 ANTIBODY, huOKT3??1 (Ala-Ala) IN THE TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION. Transplantation. 68(5). 608–616. 140 indexed citations

Richards, Jon, Julie Auger, Donna Peace, et al.. (1999). Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.. PubMed. 59(9). 2096–101. 35 indexed citations

Bachelez, H., B. Flageul, Louis Dubertret, et al.. (1998). Treatment of Recalcitrant Plaque Psoriasis with a Humanized Non-depleting Antibody to CD4. Journal of Autoimmunity. 11(1). 53–62. 42 indexed citations

Abramowicz, Daniel, Douglas J. Norman, Pierre Vereerstraeten, et al.. (1996). OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: Association with improvement in long-term survival. Kidney International. 49(3). 768–772. 39 indexed citations

Matas, Arthur, Francis L. Delmonico, R B Colvin, et al.. (1995). Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: A cooperative pilot study (report 1). Transplantation Proceedings. 27(1). 2 indexed citations

Albert, Shelley E., Frank Strutz, Kenneth Shelton, et al.. (1994). Characterization of a cis-acting regulatory element which silences expression of the class II-A beta gene in epithelium.. The Journal of Experimental Medicine. 180(1). 233–240. 17 indexed citations

10.

Haverty, Thomas P., et al.. (1994). OKT3 monoclonal antibody treatment of steroid-resistant liver transplant rejection. Current Therapeutic Research. 55(4). 382–395. 3 indexed citations

11.

Norman, Douglas J., Lawrence Kahana, Frank P. Stuart, et al.. (1993). A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATION. Transplantation. 55(1). 44–50. 113 indexed citations

12.

Blazer‐Yost, Bonnie L., et al.. (1992). Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1133(3). 329–335. 24 indexed citations

13.

Haverty, Thomas P., et al.. (1992). Tubular antigen-binding proteins repress transcription of type IV collagen in the autoimmune target epithelium of experimental interstitial nephritis.. Journal of Clinical Investigation. 89(2). 517–523. 6 indexed citations

14.

Alvarez, René, et al.. (1992). Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney International. 41(1). 14–23. 101 indexed citations

15.

Neilson, Eric G., C J Kelly, William H. Hines, et al.. (1991). Molecular characterization of a major nephritogenic domain in the autoantigen of anti-tubular basement membrane disease.. Proceedings of the National Academy of Sciences. 88(5). 2006–2010. 28 indexed citations

16.

Kuncio, Gerald S., Eric G. Neilson, & Thomas P. Haverty. (1991). Mechanisms of tubulointerstitial fibrosis. Kidney International. 39(3). 550–556. 248 indexed citations

17.

Haverty, Thomas P., M. Watanabe, Eric G. Neilson, & C J Kelly. (1989). Protective modulation of class II MHC gene expression in tubular epithelium by target antigen-specific antibodies. Cell-surface directed down-regulation of transcription can influence susceptibility to murine tubulointerstitial nephritis.. The Journal of Immunology. 143(4). 1133–1141. 27 indexed citations

18.

Haverty, Thomas P. & Eric G. Neilson. (1988). Basement membrane gene expression in polycystic kidney disease.. PubMed. 58(3). 245–8. 13 indexed citations

19.

Neilson, Eric G., C J Kelly, Michael D. Clayman, et al.. (1987). Murine interstitial nephritis. VII. Suppression of renal injury after treatment with soluble suppressor factor TsF1.. The Journal of Immunology. 139(5). 1518–1524. 13 indexed citations

20.

Neilson, Eric G., Michael D. Clayman, Thomas P. Haverty, Carolyn Kelly, & Richard A. Mann. (1986). Experimental strategies for the study of cellular immunity in renal disease. Kidney International. 30(2). 264–279. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact